Literature DB >> 66290

Priming for a cytotoxic response to minor histocompatibility antigens: antigen specificity and failure to demonstrate a carrier effect.

M J Bevan.   

Abstract

Spleen cells from normal mice do not give a detectable in vitro cytotoxic T cell (CTL) response to minor H antigens. Spleen cells from animals primed in vivo with minor H antigens give a strong CTL response when boosted in culture with the appropriate stimulating cells. Here I have studied the requirements for priming a CTL response to minor H antigens. It is shown that priming is just as antigen specific as is cytolytic effector function. That is, priming cells have to carry the same minor antigens as the challenge cells. Inducing a graft-vs-host reaction in vivo does not nonspecifically allow spleen cells to respond to minor H antigens in vitro. Using minor H congenic mice (congenic for H-Y and/or H-7) I have also tried, and failed, to demonstrate a carrier effect in priming. Female mice primed to H-Y were challenged in culture with cells bearing H-Y and H-7 antigens in the hope that a helper response to H-Y would augment a CTL response to H-7. This did not happen, however. Such primed and boosted cells gave a strong secondary CTL response to H-Y but none to H-7. It is concluded that in order to prime for a detectable in vitro response to minor antigens it is necessary to expose the CTL precursors to antigen in vivo. This either expands the size of the pool of precursors by cell division or changes them in some qualitative way.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 66290

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  A marked reduction in priming of cytotoxic CD8+ T cells mediated by stress-induced glucocorticoids involves multiple deficiencies in cross-presentation by dendritic cells.

Authors:  John T Hunzeker; Michael D Elftman; Jennifer C Mellinger; Michael F Princiotta; Robert H Bonneau; Mary E Truckenmiller; Christopher C Norbury
Journal:  J Immunol       Date:  2010-11-22       Impact factor: 5.422

2.  Recognition of allo-peptide is governed by novel anchor imposition and limited variations in TCR contact residues.

Authors:  Corbett J A Reinbold; Subramaniam Malarkannan
Journal:  Mol Immunol       Date:  2007-11-05       Impact factor: 4.407

3.  Immune Surveillance by Natural IgM Is Required for Early Neoantigen Recognition and Initiation of Adaptive Immunity.

Authors:  Shaikh M Atif; Sophie L Gibbings; Elizabeth F Redente; Faye A Camp; Raul M Torres; Ross M Kedl; Peter M Henson; Claudia V Jakubzick
Journal:  Am J Respir Cell Mol Biol       Date:  2018-11       Impact factor: 6.914

4.  Minor histocompatibility antigen expression on F9 embryonal carcinoma cells revealed by T-cell mediated responses.

Authors:  M C Simmler; P Avner; J P Levy
Journal:  Immunogenetics       Date:  1982       Impact factor: 2.846

5.  Genetics of histocompatibility in mice. III. Characteristics of the popliteal lymph-node response to minor (non-H-2) H antigens.

Authors:  L L Johnson; D W Bailey; L E Mobraaten
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

Review 6.  RNA vaccines in cancer treatment.

Authors:  Anita Bringmann; Stefanie Andrea Erika Held; Annkristin Heine; Peter Brossart
Journal:  J Biomed Biotechnol       Date:  2010-06-01

7.  Recognition of human minor alloantigen(s) by cytotoxic lymphocytes in vitro.

Authors:  W L Elkins; G Pierson; W Negendank; K S Zier
Journal:  Immunogenetics       Date:  1982       Impact factor: 2.846

8.  Differential Hm antigen expression on EC cells and early differentiated derivatives.

Authors:  M C Simmler; P R Avner
Journal:  EMBO J       Date:  1985-05       Impact factor: 11.598

9.  Influences of transporter associated with antigen processing (TAP) on the repertoire of peptides associated with the endoplasmic reticulum-resident stress protein gp96.

Authors:  D Arnold; C Wahl; S Faath; H G Rammensee; H Schild
Journal:  J Exp Med       Date:  1997-08-04       Impact factor: 14.307

10.  Cross-priming of minor histocompatibility antigen-specific cytotoxic T cells upon immunization with the heat shock protein gp96.

Authors:  D Arnold; S Faath; H Rammensee; H Schild
Journal:  J Exp Med       Date:  1995-09-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.